» Articles » PMID: 9497091

Mesencephalic Dopaminergic Neurons Expressing Neuromedin K Receptor (NK3): a Double Immunocytochemical Study in the Rat

Overview
Journal Brain Res
Specialty Neurology
Date 1998 Mar 13
PMID 9497091
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

By using a double immunocytochemical method we examined the distribution of dopaminergic neurons expressing neuromedin K receptor (NKR; NK3) in the rat brain. The distribution of NKR-like immunoreactive (-LI) neurons completely overlapped that of tyrosine hydroxylase (TH)-LI neurons in the retrorubral field (A8), substantia nigra (A9), ventral tegmental area and nucleus raphe linealis (A10). Completely or partially overlapping distributions of NKR- and TH-LI neurons were found in certain regions of the hypothalamus (A11-A15) and olfactory bulb (A16). Neurons showing both NKR- and TH-like immunoreactivities, however, were only found in A8-A10: All of the NKR-LI neurons displayed TH-like immunoreactivity, and about 71-86% of the TH-LI neurons expressed NKR-like immunoreactivity. The present results provided morphological evidence for physiological modulation of dopaminergic neurons by tachykinins through NKR in A8-A10.

Citing Articles

The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Pantaleo N, Chadwick W, Park S, Wang L, Zhou Y, Martin B CNS Neurol Disord Drug Targets. 2010; 9(5):627-35.

PMID: 20632965 PMC: 2967650. DOI: 10.2174/187152710793361504.


Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity.

Nwaneshiudu C, Unterwald E Neuropharmacology. 2009; 57(3):295-301.

PMID: 19500601 PMC: 2716396. DOI: 10.1016/j.neuropharm.2009.05.008.


The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Lessard A, Savard M, Gobeil Jr F, Pierce J, Pickel V Synapse. 2009; 63(6):484-501.

PMID: 19224600 PMC: 2742351. DOI: 10.1002/syn.20627.


The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.

Deschamps K, Couture R Br J Pharmacol. 2005; 145(6):712-27.

PMID: 15895109 PMC: 1576198. DOI: 10.1038/sj.bjp.0706249.


Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study.

Lessard A, Campos M, Neugebauer W, Couture R Br J Pharmacol. 2003; 138(4):554-63.

PMID: 12598409 PMC: 1573690. DOI: 10.1038/sj.bjp.0705042.